Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NGEN.VN | FRX.TO | MSCL.TO | ||
| Company | Nervgen Pharma Corp | Fennec Pharmaceuticals Inc | Satellos Bioscience Inc | ||
| Price Information | |||||
| Exchange | TSX Venture | TSX | TSX | ||
| Open | 4.950 | 15.98 | 12.95 | ||
| High | 5.230 | 17.00 | 12.95 | ||
| Low | 4.930 | 15.98 | 12.14 | ||
| Last | 5.150 | 17.00 | 12.75 | ||
| Change | +0.150 | +1.51 | +0.64 | ||
| Percent Change | +3.00% | +9.75% | +5.28% | ||
| Volume | 66,939 | 603 | 6,975 | ||
| 20-Day Average Volume | 49,920 | 693 | 11,766 | ||
| Previous | 5.000 | 15.49 | 12.11 | ||
| Industry | TSX Biotechnology | TSX Biotechnology | TSX Biotechnology | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 5.554 | 15.32 | 13.53 | ||
| 20-Day Raw Stochastic | 23.73% | 83.11% | 17.57% | ||
| 20-Day Relative Strength | 42.10 | 60.96 | 48.05 | ||
| Weighted Alpha | +39.45 | +34.81 | +41.76 | ||
| Today's Opinion | 8% Buy | 100% Buy | 56% Buy | ||
| Yesterday's Opinion | 24% Buy | 100% Buy | 40% Buy | ||
| Last Month's Opinion | 40% Buy | 72% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.20% since 03/09/26 | +2.97% since 08/12/26 | -5.72% since 08/24/26 | ||
| Low | 4.870 on 03/13/26 | 15.49 on 08/21/26 | 12.11 on 08/28/26 | ||
| High | 5.700 on 03/10/26 | 17.01 on 08/13/26 | 13.68 on 08/25/26 | ||
| 1-Month | |||||
| %Chg | -10.28% since 02/13/26 | +19.55% since 07/17/26 | -10.50% since 07/31/26 | ||
| Low | 4.870 on 03/13/26 | 13.85 on 07/31/26 | 12.11 on 08/28/26 | ||
| High | 6.050 on 02/23/26 | 17.64 on 08/11/26 | 14.50 on 08/19/26 | ||
| 3-Month | |||||
| %Chg | -11.21% since 12/16/25 | +23.82% since 05/26/26 | +24.06% since 05/29/26 | ||
| Low | 4.870 on 03/13/26 | 11.62 on 06/10/26 | 7.76 on 06/24/26 | ||
| High | 8.490 on 01/08/26 | 17.64 on 08/11/26 | 14.99 on 07/23/26 | ||
| 6-Month | |||||
| %Chg | +38.07% since 09/16/25 | +45.92% since 02/26/26 | -26.34% since 02/27/26 | ||
| Low | 3.200 on 11/06/25 | 7.59 on 04/13/26 | 7.67 on 04/07/26 | ||
| High | 8.490 on 01/08/26 | 17.64 on 08/11/26 | 18.98 on 03/03/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 407,944 | 596,142 | 256,931 | ||
| Shares Outstanding, K | 79,213 | 35,067 | 21,216 | ||
| Annual Sales, $M | 0 | 44,642,000 | 0 | ||
| Annual Net Income, $M | -44,117,305 | -9,741,000 | -24,873,000 | ||
| Last Qtr Sales, $M | 0 | 17,874,000 | 0 | ||
| Last Qtr Income, $M | -29,217,233 | 1,973,000 | -11,718,000 | ||
| 60-Month Beta | 0.54 | 3.55 | 1.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 11/24/25 | 0.05 on 08/13/26 | -0.56 on 08/13/26 | ||
| Latest Earnings Date | N/A | 08/11/26 | 03/26/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | N/A | N/A | ||